AntimicrobialEmerging Evidence

LL-37

Also known as: Cathelicidin, Cathelicidin antimicrobial peptide, hCAP-18

Human antimicrobial peptide with broad-spectrum activity against bacteria, fungi, and viruses.

Evidence

Emerging

FDA status

Not FDA-approved

Source

Naturally occurring human cathelicidin, synthesized therapeutically

Overview

Human antimicrobial peptide with broad-spectrum activity against bacteria, fungi, and viruses.

Mechanism of Action

Disrupts microbial membranes via carpet-like mechanism, binds LPS to neutralize endotoxins and block TLR4, inhibits biofilm formation, exhibits immunomodulatory effects through chemokine induction, promotes wound healing via TGF-β pathway.

What research has looked at

Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.

  • Broad-spectrum antimicrobial activity
  • Anti-biofilm effects
  • Neutralizes bacterial endotoxins
  • Promotes wound healing
  • Modulates immune response
  • Antiviral effects

Researched for

Research topics, not approved uses.

Chronic infectionsBiofilm-associated infectionsWounds and ulcersRespiratory infectionsSkin infections

How Gabriel approaches peptides

Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. LL-37 isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.

Read the peptide therapy guide

Research & Evidence

Evidence Level
Emerging
Studies

Extensive in vitro and preclinical studies, limited human trials

Summary

Antimicrobial effects are well described in the lab. Human data are limited to small early trials, such as for leg ulcers.

Safety Information

Potential Side Effects

  • •Injection site reactions
  • •Local irritation
  • •Cell toxicity in lab studies

Contraindications

  • Pregnancy
  • Breastfeeding

Interactions

  • ⚠Unknown

Quick Facts

CategoryAntimicrobial
SourceNaturally occurring human cathelicidin, synthesized therapeutically
StatusNot FDA-approved